47 results
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
26 Jun 24
DiaMedica Therapeutics Announces $11.8 Million
8:16am
), Medicare, Title XVIII of the Social Security Act, and Medicaid, Title XIX of the Social Security Act, and the regulations promulgated pursuant
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
5 Sep 23
Departure of Directors or Certain Officers
4:15pm
without limitation all social security and self-employment taxes, and DiaMedica (unless required by applicable tax authorities) will not withhold
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am
Protection Regulation (EU 2016 679), Medicare, Title XVIII of the Social Security Act, and Medicaid, Title XIX of the Social Security Act
8-K
EX-10.2
t9he19uk
25 May 22
Departure of Directors or Certain Officers
4:49pm
8-K
EX-10.1
rwcsq81yypsj6vuwbj
27 Sep 21
DiaMedica Therapeutics Announces $30 Million
8:45am
8-K
EX-1.1
c7lkp9hxfm
10 Aug 20
DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares
12:00am
8-K
EX-99.1
ejzv8fcf
23 Mar 20
DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update
4:31pm
DEF 14A
vf4qe2c6 zeb2sz
8 Apr 19
Definitive proxy
6:04am
PRE 14A
vxtpz9tjh3fc5 vu
20 Mar 19
Preliminary proxy
4:31pm
8-K
EX-10.1
auo9c ya2umkuxs65wb
11 Dec 18
Diamedica Announces Pricing of Initial Public Offering and Nasdaq Listing
4:06pm